New Delhi, Jan. 28 -- Dr. Agarwal's Health Care Ltd's initial public offering (IPO) represents a milestone for India's specialized healthcare sector. With a strong operational model, robust financials, and a clear growth strategy, the company is eyeing the pole position in the expanding eye care market.

The public issue, which combines a fresh issue of Rs.300 crore and an offer-for-sale (OFS) of Rs.2,727 crore, aims to raise a total of Rs.3,027 crore. With a valuation pegged at Rs.12,810 crore at the upper price band of Rs.402 per share, the company is digging in for a new phase of growth and consolidation in the burgeoning segment.

However, the high valuation and the significant OFS component necessitate a cautious approach for potenti...